Similarly, SLAMF7 expression (or lack thereof) did not correlate with the extent of phagocytosis induced upon treatment of a B-NHL cell line panel with CD20 antibody rituximab alone (Fig. 3g) or upon combination treatment with rituximab and inhibrix (Fig. 3h, i). This evidence concerns the gene SLAMF7 and non-Hodgkin lymphoma.